Cargando…
Management of Condyloma Acuminata in Pregnancy: A Review
No clear guidelines are available for the management of pregnant women with condyloma acuminata, a human papillomavirus–associated benign neoplasm that develops in the genital tract. We performed a systematic review to gain a better understanding of the management of condyloma acuminata during pregn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132606/ https://www.ncbi.nlm.nih.gov/pubmed/33093288 http://dx.doi.org/10.1097/OLQ.0000000000001322 |
_version_ | 1783694940893609984 |
---|---|
author | Sugai, Shunya Nishijima, Koji Enomoto, Takayuki |
author_facet | Sugai, Shunya Nishijima, Koji Enomoto, Takayuki |
author_sort | Sugai, Shunya |
collection | PubMed |
description | No clear guidelines are available for the management of pregnant women with condyloma acuminata, a human papillomavirus–associated benign neoplasm that develops in the genital tract. We performed a systematic review to gain a better understanding of the management of condyloma acuminata during pregnancy. In this review, we mainly focused on treatments. We searched PubMed, Google Scholar, and Web of Science to identify studies on the treatment of condyloma acuminata during pregnancy. Thirty articles met the inclusion criteria. The treatment methods described in the literature were laser therapy, cryotherapy, imiquimod, photodynamic therapy, trichloroacetic acid, and local hyperthermia. The most effective treatment remains unclear. Various factors must be considered when deciding how to treat. Based on our assessment of the literature, we recommend cryotherapy as the first-choice treatment and laser therapy as the second-choice treatment. Imiquimod can be considered in cases such as extensive condyloma acuminata that is not easily treated by cryotherapy or laser therapy. In such cases, sufficient informed consent must be obtained from the patient. Cryotherapy, laser therapy, and imiquimod have been administered during all 3 trimesters with no severe adverse effects, but we cautiously recommend reserving laser therapy until the third trimester because of the lower risk of recurrence before delivery. There are still many unclear points regarding the management of condyloma in pregnancy, and further research is needed. |
format | Online Article Text |
id | pubmed-8132606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-81326062021-05-20 Management of Condyloma Acuminata in Pregnancy: A Review Sugai, Shunya Nishijima, Koji Enomoto, Takayuki Sex Transm Dis Reviews No clear guidelines are available for the management of pregnant women with condyloma acuminata, a human papillomavirus–associated benign neoplasm that develops in the genital tract. We performed a systematic review to gain a better understanding of the management of condyloma acuminata during pregnancy. In this review, we mainly focused on treatments. We searched PubMed, Google Scholar, and Web of Science to identify studies on the treatment of condyloma acuminata during pregnancy. Thirty articles met the inclusion criteria. The treatment methods described in the literature were laser therapy, cryotherapy, imiquimod, photodynamic therapy, trichloroacetic acid, and local hyperthermia. The most effective treatment remains unclear. Various factors must be considered when deciding how to treat. Based on our assessment of the literature, we recommend cryotherapy as the first-choice treatment and laser therapy as the second-choice treatment. Imiquimod can be considered in cases such as extensive condyloma acuminata that is not easily treated by cryotherapy or laser therapy. In such cases, sufficient informed consent must be obtained from the patient. Cryotherapy, laser therapy, and imiquimod have been administered during all 3 trimesters with no severe adverse effects, but we cautiously recommend reserving laser therapy until the third trimester because of the lower risk of recurrence before delivery. There are still many unclear points regarding the management of condyloma in pregnancy, and further research is needed. Lippincott Williams & Wilkins 2021-06 2020-10-22 /pmc/articles/PMC8132606/ /pubmed/33093288 http://dx.doi.org/10.1097/OLQ.0000000000001322 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Reviews Sugai, Shunya Nishijima, Koji Enomoto, Takayuki Management of Condyloma Acuminata in Pregnancy: A Review |
title | Management of Condyloma Acuminata in Pregnancy: A Review |
title_full | Management of Condyloma Acuminata in Pregnancy: A Review |
title_fullStr | Management of Condyloma Acuminata in Pregnancy: A Review |
title_full_unstemmed | Management of Condyloma Acuminata in Pregnancy: A Review |
title_short | Management of Condyloma Acuminata in Pregnancy: A Review |
title_sort | management of condyloma acuminata in pregnancy: a review |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132606/ https://www.ncbi.nlm.nih.gov/pubmed/33093288 http://dx.doi.org/10.1097/OLQ.0000000000001322 |
work_keys_str_mv | AT sugaishunya managementofcondylomaacuminatainpregnancyareview AT nishijimakoji managementofcondylomaacuminatainpregnancyareview AT enomototakayuki managementofcondylomaacuminatainpregnancyareview |